| 1 |
35236323 | Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma. | 2022 Mar 2 |
4 |
| 2 |
35261780 | Cisplatin plus anti-PD-1 antibody enhanced treatment efficacy in advanced esophageal squamous cell carcinoma. | 2022 |
5 |
| 3 |
35547095 | Current status and advances of immunotherapy in nasopharyngeal carcinoma. | 2022 |
2 |
| 4 |
32935617 | Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial Carcinoma. | 2021 Feb |
3 |
| 5 |
33355035 | Epidemiology and treatment patterns for locally advanced or metastatic urothelial carcinoma: a systematic literature review and gap analysis. | 2021 Feb |
1 |
| 6 |
33430352 | Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti-PD-1 Treatment Efficacy in Urothelial Carcinoma. | 2021 Jan 7 |
1 |
| 7 |
33581579 | PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression. | 2021 May |
2 |
| 8 |
33656040 | Cisplatin nanoparticles boost abscopal effect of radiation plus anti-PD1 therapy. | 2021 Apr 21 |
4 |
| 9 |
32341383 | Effects of anti-PD-1 immunotherapy on tumor regression: insights from a patient-derived xenograft model. | 2020 Apr 27 |
1 |
| 10 |
30582240 | PD-1 and PD-L1 in locoregionally advanced nasopharyngeal carcinoma: Substudy of a randomized phase III trial. | 2019 May |
1 |
| 11 |
30940805 | Crizotinib-induced immunogenic cell death in non-small cell lung cancer. | 2019 Apr 2 |
2 |
| 12 |
31086347 | Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. | 2019 Jun |
1 |
| 13 |
29325739 | Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development. | 2018 Apr |
3 |
| 14 |
30126243 | Cellular Pharmacology of Palladinum(III) Hematoporphyrin IX Complexes: Solution Stability, Antineoplastic and Apoptogenic Activity, DNA Binding, and Processing of DNA-Adducts. | 2018 Aug 19 |
4 |
| 15 |
28730785 | PDCD1 strengthens the sensitivity of ovarian cancer to cisplatin chemotherapy by promoting apoptosis. | 2017 May-Jun |
5 |
| 16 |
28801607 | Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition. | 2017 Aug 11 |
2 |
| 17 |
28819582 | Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer. | 2017 Jun |
2 |
| 18 |
28994323 | Atezolizumab in invasive and metastatic urothelial carcinoma. | 2017 Dec |
1 |
| 19 |
27610620 | Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells. | 2016 |
4 |